|

JNJ-87189401 Clinical Trials

3 actively recruiting trials across 3 locations

▲ +2 trials since August 2026

Also known as: PSMAxCD28

Pipeline

Phase 1: 2Phase 3: 1

Top Sponsors

  • Janssen Research & Development, LLC3

Indications

  • Cancer3
  • Prostatic Neoplasms2
  • Metastatic Castration-resistant Prostatic Neoplasms1
  • Metastatic Castration-resistant Prostate Neoplasms1
  • Advanced Prostate Cancer1

La Jolla, California1 trial

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

University of California at San Diego

Phase 3

Aurora, Colorado1 trial

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

University of Colorado Anschutz Medical Campus

Phase 1

Sarasota, Florida1 trial

A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

Florida Cancer Specialists

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.